Advisor Group Holdings, Inc. Charles River Laboratories International, Inc. Transaction History

Advisor Group Holdings, Inc.

  • $42.1 Billion
  • Q1 2025

A detailed history of Advisor Group Holdings, Inc. transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Advisor Group Holdings, Inc. holds 875 shares of CRL stock, worth $121,178. This represents 0.0% of its overall portfolio holdings.

Number of Shares
875
Previous 3,757 76.71%
Holding current value
$121,178
Previous $693,000 81.1%
% of portfolio
0.0%
Previous 0.0%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 12, 2025
SELL
$150.52 - $190.14 $433,798 - $547,983
-2,882 Reduced 76.71%
875 $131,000
Q4 2024

Feb 07, 2025
SELL
$178.58 - $220.69 $263,941 - $326,179
-1,478 Reduced 28.23%
3,757 $693,000
Q3 2024

Nov 13, 2024
SELL
$187.96 - $245.29 $128,188 - $167,287
-682 Reduced 11.53%
5,235 $1.03 Million
Q2 2024

Aug 13, 2024
BUY
$206.39 - $268.73 $91,843 - $119,584
445 Added 8.13%
5,917 $1.22 Million
Q1 2024

May 10, 2024
SELL
$203.52 - $273.43 $3.53 Million - $4.75 Million
-17,365 Reduced 76.04%
5,472 $1.48 Million
Q4 2023

Feb 12, 2024
SELL
$164.52 - $238.84 $2.12 Million - $3.08 Million
-12,882 Reduced 36.06%
22,837 $5.4 Million
Q3 2023

Nov 13, 2023
BUY
$194.44 - $217.61 $2.19 Million - $2.45 Million
11,246 Added 45.95%
35,719 $7 Million
Q2 2023

Aug 10, 2023
SELL
$183.71 - $210.25 $448,068 - $512,799
-2,439 Reduced 9.06%
24,473 $5.15 Million
Q1 2023

May 12, 2023
SELL
$191.89 - $259.92 $46,245 - $62,640
-241 Reduced 0.89%
26,912 $5.43 Million
Q4 2022

Feb 10, 2023
SELL
$197.11 - $250.07 $244,416 - $310,086
-1,240 Reduced 4.37%
27,153 $5.91 Million
Q3 2022

Nov 14, 2022
SELL
$182.44 - $250.54 $1.23 Million - $1.68 Million
-6,720 Reduced 19.14%
28,393 $5.59 Million
Q2 2022

Aug 10, 2022
SELL
$204.13 - $302.4 $687,713 - $1.02 Million
-3,369 Reduced 8.75%
35,113 $7.51 Million
Q1 2022

May 04, 2022
BUY
$255.51 - $362.11 $2.24 Million - $3.17 Million
8,750 Added 29.43%
38,482 $14.2 Million
Q3 2021

Nov 05, 2021
BUY
$372.64 - $458.3 $2.14 Million - $2.63 Million
5,735 Added 23.9%
29,732 $12.3 Million
Q2 2021

Aug 02, 2021
BUY
$294.17 - $371.65 $1.41 Million - $1.78 Million
4,796 Added 24.98%
23,997 $8.88 Million
Q1 2021

May 13, 2021
BUY
$249.67 - $299.48 $431,679 - $517,800
1,729 Added 9.9%
19,201 $5.57 Million
Q4 2020

Feb 10, 2021
BUY
$222.0 - $252.62 $490,176 - $557,784
2,208 Added 14.47%
17,472 $4.36 Million
Q3 2020

Nov 12, 2020
BUY
$175.56 - $226.45 $279,140 - $360,055
1,590 Added 11.63%
15,264 $3.41 Million
Q2 2020

Aug 14, 2020
BUY
$118.84 - $189.72 $225,082 - $359,329
1,894 Added 16.08%
13,674 $2.39 Million
Q1 2020

May 18, 2020
BUY
$98.9 - $178.34 $1.17 Million - $2.1 Million
11,780 New
11,780 $1.49 Million

Others Institutions Holding CRL

# of Institutions
648
Shares Held
55M
Call Options Held
695K
Put Options Held
809K
View Full List

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

CRL Quotes by TradingView
  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $7.04B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track Advisor Group Holdings, Inc. Portfolio

Follow Advisor Group Holdings, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Advisor Group Holdings, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email